Advances in vulvar and vaginal cancer treatment

Gynecologic Oncology

Volumn 118, Issue 1, 2010, Pages 3-5

  Gray, Heidi J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CISPLATIN; ERLOTINIB; FLUOROURACIL; MITOMYCIN C;

ANUS CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL TRIAL; EDITORIAL; HUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; VAGINA CANCER; VULVA CANCER;

FEMALE; HUMANS; NEOPLASM STAGING; VAGINAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 77953291228     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.04.011     Document Type: Editorial

References (38)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., and Thun M.J. Cancer statistics, 2009. CA Cancer J Clin 59 (2009) 225-249
2. Homesley H.D., Bundy B.N., Sedlis A., et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol 164 (1991) 991-1004
3. Hacker N.F. Revised FIGO staging for carcinoma of the vulva. Int J Gynecol Obstet 105 (2009) 105-106
4. Hacker N.F., Berek J.S., Lagasse L.D., Leuchter R.S., and Moore J.G. Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol 61 (1983) 408-412
5. Origoni M., Sideri M., Garsia S., Carinelli S.G., and Ferrari A.G. Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO. Gynecol Oncol 45 (1992) 313-316
6. Paladini D., Cross P., Lopes A., and Monaghan J.M. Prognostic significance of lymph node variables in squamous cell carcinoma of the vulvar. Cancer 74 (1994) 2491-2496
7. van der Velden J., van Lindert A.C., Lammes F.B., et al. Extracapsular growth of lymph node metastasis in squamous cell carcinoma of the vulva. Cancer 75 (1995) 2885-2890
8. Pecorelli S. FIGO Committee on Gynecologic Oncology. Revised staging for carcinoma of the vulva, cervix and endometrium. Int J Gynecol Obstet 105 (2009) 103-104
9. Taussig F.J. Cancer of the vulva: an analysis of 155 cases (1911-1940). Am J Obstet Gynecol 40 (1940) 764-769
10. Way S. Carcinoma of the vulva. Am J Obstet Gynecol 79 (1960) 692-699
11. Podratz K.C., Symmonds R.E., Taylor W.F., and Williams T.J. Carcinoma of the vulva: analysis of treatment and survival. Obstet Gynecol 61 (1983) 63-74
12. Stehman F.B., and Look K.Y. Carcinoma of the vulva. Obstet Gynecol 107 (2006) 719-733
13. Hacker N.F., Leuchter R.S., Berek J.S., et al. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol 58 (1981) 574
14. Van der Zee A.G., Oonk M.H., De Hullu J.A., et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 26 (2008) 884-889
15. Oonk M.H.M., van Os M.A., de Bock G.H., de Hullu J.A., Ansink A.C., and van der Zee A.G.J. A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy. Gynecol Oncol 113 (2009) 301-305
16. Levenback C.F., Tian C., Coleman R.L., et al. Sentinel node (SN) biopsy in patients with vulvar cancer: A Gynecologic Oncology Group (GOG) study. J Clin Oncol 27 (2009) 15s [suppl; abstr 5505]
17. Moore R.G., DePasquale S.E., Steinhoff M.M., et al. Sentinel node identification and the ability to detect metastatic tumor to inguinal lymph nodes in squamous cell cancer of the vulva. Gynecol Oncol 89 (2003) 475-479
18. Levenback C., Coleman R.L., Burke T.W., et al. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol 83 (2001) 276-281
19. Terada K.Y., Shimizu D.M., Jiang C.S., and Wong J.H. Outcomes for patients with T1 squamous cell cancer of the vulva undergoing sentinel node biopsy. Gynecol Oncol 102 (2006) 200-203
20. Stehman F.B., Bundy B.N., Dvoretsky P.M., and Creasman W.T. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol 79 (1992) 490-497
21. Stroup A.M., Harlan L.C., and Trimble E.L. Demographic, clinical and treatment trends among women diagnosed with vulvar cancer in the United States. Gynecol Oncol 108 (2008) 1577-1583
22. Thomas G., Dembo A., DePetrillo A., et al. Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol Oncol 34 (1989) 263-267
23. Whalen S.A., Slater J.D., Wagner R.J., et al. Concurrent radiation and chemotherapy in the treatment of primary squamous cell cancer of the vulva. Cancer 75 (1995) 2289-2294
24. Landoni F., Maneo A., Zanetta G., et al. Concurrent preoperative chemotherapy with 5-flourouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecol Oncol 61 (1996) 321-327
25. Lupi F., Raspagliesi F., Zucali R., et al. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced and recurrent vulvar carcinoma: a pilot study. Cancer 77 (1996) 1472-1478
26. Koh W.J., Wallace H.J., Greer B.E., et al. Combined radiotherapy in the management of local-regionally advanced vulvar cancer. Int J Radiat Oncol Biol Phys 26 (1993) 809-816
27. Berek J.S., Heaps J.M., Fu Y.S., et al. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva. Gynecol Oncol 42 (1991) 197-201
28. Russell A.H., Mesic J.B., Scudder S.A., et al. Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva. Gynecol Oncol 47 (1992) 14-20
29. Eifel P.J., Morris M., Burke T.W., Levenback C., and Gershenson D.M. Preoperative continuous infusion cisplatinum and 5-fluorouracil with radiation for locally advanced or recurrent carcinoma of the vulva. Gynecol Oncol 59 (1995) 51-56
30. Moore D.H. Chemotherapy and radiation therapy in the treatment of squamous cell carcinoma of the vulva: are two therapies better than one?. Gynecol Oncol 113 (2009) 379-383
31. Moore D.H., Thomas G.M., Montana G.S., et al. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 42 (1998) 79-85
32. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340 (1999) 1154-1162
33. Peters W.A., Liu P.Y., Barrett R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1610
34. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1147
35. Horowitz N., Olawiye A., Growdon W., et al. Phase II trial of erlotinib (Tarceva) in women with squamous cell carcinoma of the vulva. Abstract. Gynecol Oncol 116 (2010) S14
36. Shah C.A., Goff B.A., Lowe K., Peters W.A., and Li C.I. Factors affecting risk of mortality in women with vaginal cancer. Obstet Gynecol 113 (2009) 1038-1045
37. Dalrymple J.L., Russell A.H., Lee S.W., et al. Chemoradiation for primary invasive squamous carcinoma of the vagina. Int J Gynecol Cancer 14 (2004) 110-117
38. Samant R., Lau B., Choan E., Le T., and Tam T. Primary vaginal cancer treated with concurrent chemoradiation using Cis-platinum. Int J Radiat Oncol Biol Phys 69 (2007) 746-750